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In recent years, there has been an increase in resistance of malaria vectors to insecticides, particularly to pyrethroids
which are widely used in insecticide-treated nets. The Global Plan for Insecticide Resistance Management in malaria
vectors (GPIRM), released in May 2012, is a collective strategy for the malaria community to tackle this challenge.
This review outlines progress made to date and the challenges experienced in the implementation of GPIRM, and
outlines focus areas requiring urgent attention. Whilst there has been some advancement, uptake of GPIRM at the
national level has generally been poor for various reasons, including limited availability of vector control tools with
new mechanisms of action as well as critical financial, human and infrastructural resource deficiencies. There is an
urgent need for a global response plan to address these deficits and ensure the correct and efficient use of available
tools in order to maintain the effectiveness of current vector control efforts whilst novel vector control tools are under
development. Emphasis must be placed on enhancing national capacities (such as human and infrastructural resources)
to enable efficient monitoring and management of insecticide resistance, and to support availability and accessibility of
appropriate new vector control products. Lack of action by the global community to address the threat of insecticide
resistance is unacceptable and deprives affected communities of their basic right of universal access to effective malaria
prevention. Aligning efforts and assigning the needed resources will ensure the optimal implementation of GPIRM with
the ultimate goal of maintaining effective malaria vector control.
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Between 2000 and 2013, worldwide malaria morbidity
and mortality rates were almost halved. The greatest de-
clines have been observed in the WHO African Region,
where the burden of disease remains highest [1]. These
impressive reductions have been achieved largely due to
the widespread deployment of insecticide-treated nets
(ITNs) and indoor residual spraying (IRS) of insecticides,
which target Anopheles malaria vectors. However, the ef-
fectiveness of these core malaria interventions is threat-
ened by increases in the distribution and strength
(intensity) of insecticide resistance in these mosquitoes
[2-4]. This is of particular concern for pyrethroids,* Correspondence: mnzavaa@who.int
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unless otherwise stated.which are currently the only insecticides used in ITNs
and are also widely applied in IRS.
In recognition of the threat of insecticide resistance,
the WHO Global Malaria Programme convened an ex-
pert consultation in 2010 to inform the development of
an appropriate and comprehensive response to insecti-
cide resistance [5]. GPIRM was prepared, and released
in May 2012 [6]. The Plan is a collective strategy aimed
at maintaining the effectiveness of malaria vector con-
trol, and is comprised of five pillars to guide global, re-
gional and national action in the short-, medium- and
long-term (Figure 1).
Since the initial consultation and the release of GPIRM
the insecticide resistance situation has worsened, particu-
larly in the WHO African Region. Information from the
recently-established WHO global insecticide resistance
database indicates that since 2010, pyrethroid resistanceal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Five pillars of the Global Plan for Insecticide Resistance Management in malaria vectors. Excerpt from GPIRM [6].
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species in 78% of countries that reported monitoring data
(Figure 2); resistance to two or more insecticide classes
was reported for 80% of those [1]. Stronger resistance
mechanisms have been detected in Anopheles gambiae s.s.
from West Africa, in addition to the target site mutations
and metabolic-based mechanisms identified previously [7].
This has resulted in elevated levels of resistance rising up to
1,000-fold and the emergence of cross-resistance to add-
itional insecticides [8]. There is emerging evidence that in-
secticide resistance is already compromising the effectiveness
of malaria control efforts [3,9,10]. Meanwhile, the arsenal of
WHO-recommended insecticides has remained limited to
pyrethroids for ITNs, with these and three additional insecti-
cide classes recommended for IRS. Five classes of larvicides
are also recommended, though their use is not widespread.
Against this background of escalating resistance and lim-
ited vector control tools, as well as global finances that con-
tinue to fall short of estimated requirements for malaria
control and elimination [1] and restricted entomological cap-
acity [11], there has been some progress in the implementa-
tion of GPIRM. This case study reviews the progress made,
the challenges experienced to date, and proposes key actions
for accelerating global efforts to provide sustainable univer-
sal access to effective malaria vector control. It builds on
the report issued to the Malaria Policy Advisory Committee
(MPAC) in September 2014 [12] and provides additional
data on insecticide resistance and entomological capacity
obtained from WHOMember States in 2014.
PILLAR I Plan and implement insecticide resistance
management strategies in malaria-endemic countries
Seven countries in Africa reported having established a na-
tional insecticide resistance monitoring and managementplan by September 2014: Equatorial Guinea, Eritrea,
Mozambique, Rwanda, South Africa, United Republic of
Tanzania, and Zambia. Plans are being developed in most
other countries in sub-Saharan Africa but this process has
yet to be commenced in the vast majority of countries out-
side of the region. The quality and viability of existing plans
is also variable, with few formulated on the basis of pre-
emptive action to prevent resistance emergence but most
instead developed as a response to detected resistance.
To address the need for additional and better quality
plans, a framework that outlines the structure and content
required for a national plan was developed by WHO in
2014 and is undergoing field testing [13]. National insecti-
cide resistance management strategies should be formu-
lated on the basis of existing vector control interventions,
status of insecticide resistance and epidemiological con-
text [6]. In principle, good resistance management prac-
tice requires the application of multiple insecticides of
differentbiochemicalmodesof action (MOA) in rotations,mo-
saics, mixtures, or by combining multiple interventions [6]. In
practice, pyrethroid long-lasting insecticidal nets (LLINs)
are the principal malaria vector control tool used in the
majority of malaria-endemic settings and therefore IRS of-
fers the main option for resistance management. Moreover,
insecticides of only two biochemicalMOA [14] are currently
recommended by WHO for IRS in malaria vector control:
sodium channel modulators (pyrethroids, DDT) and acetyl-
cholinesterase inhibitors (carbamates, organophosphates)
[15]. These insecticide formulations are also recommended
for the control of other indoor-resting and -biting vectors.
Rotation of IRS insecticides by MOA on an annual basis is
currently thebestpractice for resistancemanagement inmalaria
vectors in most settings. Mosaics are often not operationally or
financially feasible due to the need for multiple procurements
Figure 2 Status of pyrethroid resistance in malaria vectors and national insecticide resistance monitoring and management plans. Reported
resistance status based on standard WHO susceptibility tests and CDC bottle assays using criteria of confirmed resistance (<90% mortality),
possible resistance requiring confirmation (90-97% mortality) and susceptibility (≥98% mortality) with the lowest mortality displayed if multiple
insecticides, vectors or time points were tested for a single locality. Status of national plans based on capacity assessment reports provided to
WHO, September 2014.
Mnzava et al. Malaria Journal  (2015) 14:173 Page 3 of 9from different sources, and variations in training and
waste disposal procedures. Mixtures are not yet available
for IRS due to the potential for increased cost and the dif-
ficulty of developing formulations that contain multiple
active ingredients with long-lasting residual activity, posi-
tive synergistic interaction and acceptable safety profiles.
Combining IRS and ITNs specifically for resistance man-
agement purposes [16] may be difficult to justify finan-
cially where there are insufficient resources to cover the
at-risk population with a single and effective vector control
tool for disease control purposes. Larval source manage-
ment may provide an opportunity for resistance manage-
ment since there is greater diversity in MOAs of larvicides
and habitat modification/manipulation can reduce overall
dependence on insecticides but interventions targeting lar-
vae are appropriate in certain settings only.
There has been a shift away from the use of pyrethroids in
IRS, with seven countries that used this class in 2011/2012
reporting exclusive use of non-pyrethroids in 2013 [1].
However, changing to use of a non-pyrethroid class has
invariably been driven by the detection of high-level pyr-
ethroid resistance, rather than the proactive implementa-
tion of good resistance management practice as part of along-term national strategy. For most countries, the change
to non-pyrethroid IRS was associated with a reduction in
the overall proportion of the at-risk population protected
by IRS as a result of the increased cost of procuring and
deploying non-pyrethroid alternatives [1]. For example,
while pyrethroids require two spray rounds in areas with a
malaria transmission season beyond six months and are
approximately USD2-3 per sachet (for coverage of an esti-
mated 250 square meters of surface area), a new long-
lasting organophosphate (pirimiphos-methyl) formulation
requires one spray round per season and is approximately
USD23 for equivalent coverage. Once application costs are
taken into account, the cost of spraying one round of the
long-lasting organophosphate formulation may be similar
to that required for two rounds of a pyrethroid. However,
in reality, even countries with perennial transmission often
do not spray with sufficient frequency to ensure year-
round effective coverage.
Global coverage rates of at-risk populations with IRS
have decreased annually from 5% (185 million people
protected) in 2010 to 4% (124 million) in 2013 [1]. As
the use of IRS declines, so too do the opportunities for
insecticide resistance management using current tools.
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resistance monitoring and effective data management
GPIRM outlined the importance of routinely collecting,
analysing, managing, and sharing data on insecticide re-
sistance to support timely and informed programmatic
decision-making. For 2013, 77 countries reported con-
ducting insecticide resistance monitoring of some form,
although monitoring data were provided to WHO by
only 42 countries [1]. This disparity is likely due to the
fact that resistance monitoring is not necessarily con-
ducted on an annual basis and there may be delays or
barriers to reporting all monitoring data to the national
malaria control programme within three months of test-
ing, as recommended in GPIRM.
When conducted, resistance monitoring seldom in-
cludes testing of all major malaria vector species with
each of the four insecticide classes. Lack of continuity in
data collection precludes the identification of temporal
and spatial trends. Issues with the consolidation and dis-
semination of monitoring data at the national level are
often due to reticence of those who conduct monitoring
to share the data for various reasons, including a mis-
conception that this will prevent publication in scientific
journals.
It is essential that national programmes are at the
centre of any monitoring initiatives, including the man-
agement and dissemination of arising data, since the im-
petus is for this to improve the impact of vector control.
A generally low capacity in data management within na-
tional malaria control programmes is however a major
limitation in many countries; in 2014, only 34 malaria-
endemic countries reported the existence of a national
insecticide resistance database with seven countries
planning to develop a database in 2014/2015. It is im-
portant that partners supporting or conducting insecti-
cide resistance monitoring also invest in building the
necessary national capacity and structures to manage the
resistance data.
A global database has been established by WHO at the
request of Member States to consolidate insecticide re-
sistance data reported by countries and partners sup-
porting monitoring along with data extracted from
scientific publications. By the end of 2014, the global
database contained information from 2,019 sites in 71
countries for 110 vector species from both WHO sus-
ceptibility assays and USA Centers for Disease Control
and Prevention (CDC) bottle bioassays. Limited data
were included on resistance mechanisms, although the
published literature contains extensive information par-
ticularly for countries such as Burkina Faso, Benin and
Kenya [17]. Consolidation of available resistance mech-
anism data will be undertaken in 2015. Plans are in pro-
gress to develop interactive maps to display selected
aggregate national data and geo-referenced sub-nationaldata, due to the complexity of interpreting information
from multiple years, species, insecticides, or mechanisms.
These information management tools will facilitate data
sharing and timely availability to guide national and global
malaria policy.
An updated version of the test procedures for insecti-
cide resistance monitoring in malaria vector mosquitoes
was released in April 2013 [18]. This has served to im-
prove standardization of testing and reporting. However,
current bioassay tests which measure mortality in re-
sponse to a fixed concentration of a given insecticide over
a set time period are liable to variation depending on test
conditions (e.g., temperature, humidity, age of test mos-
quitoes), and whilst they may give an indication of resist-
ance frequency according to set criteria, they are not
sufficient for measuring resistance strength or predicting
impact on intervention efficacy. Additional resistance test-
ing methods are clearly needed; their development and
uptake must be informed by sufficient cross-laboratory
and field validation. For example, evidence on the use of
the CDC bottle bioassay to measure resistance strength
will be reviewed by the WHO Vector Control Technical
Expert Group (VCTEG) to determine its utility and prac-
ticality for routine insecticide resistance monitoring by
control programmes.
Development of technical competency through train-
ing is also key to supporting sound insecticide resistance
monitoring and management. A number of regional and
national training courses focussed on insecticide resist-
ance have been conducted since the release of GPIRM.
Numerous partners have been commendably involved in
coordinating training workshops on insecticide resist-
ance monitoring and have assisted with provision of the
necessary equipment to the countries in which they op-
erate. These have focused on imparting knowledge and
skills to national technicians on the collection of data,
rather than the skills to correctly analyse, interpret and
manage the data to better inform control. The critical
need remains in many countries for resources and hu-
man capacity to collect, manage and share entomological
data as well as use the data appropriately [11] to guide
the management of insecticide resistance. Resources are
also required within WHO to support countries in co-
ordinating the implementation of technical recommen-
dations outlined in GPIRM and other relevant vector
control policies.
Pillar III Develop new, innovative vector control tools
Whilst current insecticide resistance management efforts
focus on judicious use of existing interventions, the de-
velopment and adoption of LLIN and IRS formulations
with new MOA is essential for resistance management
in the medium- to long-term. Biological and environ-
mental appropriateness are also key considerations, and
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profiles (TPP), with validation including social compli-
ance (acceptability) and assessment of scalability and
cost [19]. The pipeline of new insecticide-based vector
control products has dramatically improved in the past
ten years, mainly due to the Innovative Vector Control
Consortium (IVCC) product development partnership
(Table 1). In the longer term, new interventions are also
needed to address residual malaria transmission whilst
providing effective options for insecticide resistance
management.
For novel or improved interventions to reach the mar-
ket and become available for implementation in the pre-
dicted timeframe, the global and national regulatory
framework, including efficacy and safety assessments,
will need to be adapted since these are often appropriate
for existing vector control paradigms only. The success-
ful deployment of new tools and strategies will require
multisectoral coordination across numerous stakeholder
groups, led by national malaria control programmes and
including national registration bodies, environmental
ministries, researchers, and vector control commodity
suppliers. Continuity in the core group will ensure
knowledge and experience retention, though supplemen-
tary support from external experts may be sought as re-
quired. Alongside innovation in product development
and harmonization of policy and and regulatory pro-
cesses funding mechanisms and supply chains must be
optimized to achieve cost-effective and sustainable vec-
tor control.
To aid development and ensure appropriate technical
recommendation for new vector control paradigms, the
WHO Vector Control Advisory Group (VCAG) was
constituted in 2012. The group is jointly managed by the
WHO Global Malaria Programme and the Department
of Control of Neglected Tropical Diseases, and assesses
the potential public health benefits of new paradigms,
tools and technologies for vector control. Following an
initial recommendation on the new paradigm, an over-Table 1 New insecticidal products for malaria vector control
Intervention Status
Indoor residual sprays Two new long-lasting formulations of existing IRS
months, to 6–12 months have already reached th
development, but are at best 12–24 months from
of novel active ingredient candidates that should
Long-lasting
insecticidal nets
New formulations are in preparation, with the firs
regulator. An important step will be to examine po
generation of non-pyrethroid multi-insecticide nets
availability for wide-scale deployment.
Spatial repellents Currently there are insufficient data to assess whe
prevention. A multi-country field trial of the effectiv
work against most or just a small sub-set of mosqu
recommend wide-scale usage of repellents as part
and research groups will be required to identify an
Information provided by the IVCC.arching TPP can be established and the WHO Pesticide
Evaluation Scheme may then proceed with the validation
of individual product safety and efficacy using product
specifications derived from this TPP. The outcome of
the VCAG process will be to shorten the time from de-
velopment to deployment of newly validated vector con-
trol tools to protect populations from malaria and other
vector-borne diseases. To date, VCAG has established its
working procedures and has reviewed 18 dossiers from
innovators of potential tools and technologies of public
health importance; a list of paradigms currently under
consideration can be found on the website [20]. VCAG
is currently developing guidelines on the minimum data
required for evaluating products of new paradigms in-
cluding LLINs with a claim of improved efficacy against
pyrethroid-resistant malaria vectors, and the VCTEG is
developing guidance defining operational conditions for
their deployment.
Pillar IV Fill gaps in knowledge on mechanisms of
insecticide resistance and the impact of current
insecticide resistance management approaches
GPIRM sets out priorities for research in the short-,
medium- and long-term, although it emphasized that the
lack of full information and evidence in some key areas
need not preclude pre-emptive action to address insecti-
cide resistance. Since the release of GPIRM, progress has
been made in some but not all priority areas.
Evidence on sub-regional and regional trends in the
spread of resistance in locally important vector species is
being compiled through WHO global and regional data-
bases, and will be reviewed periodically. There has been
significant investment by various institutes in character-
izing and monitoring metabolic resistance mechanisms in
recent years; consequently, the time required to identify
the underlying causes of resistance has been reduced from
six to 12 months to a matter of weeks, although the
process still requires technical and infrastructural capacity
that exceeds what is currently available in most malaria-insecticides but with increased longevity beyond the benchmark of 2–4
e market. Other formulations of repurposed agro-chemicals are under
becoming available for deployment. IVCC has established a portfolio
deliver new public health insecticides by 2022.
t generation of these containing a pyrethroid plus a synergist or growth
tential additional benefits against pyrethroid-resistant Anopheles. A second
is in early stage development but it is likely to be several years before
ther spatial repellents could play a substantive role in malaria disease
eness of repellents is under way which should establish whether repellents
ito vectors, but this study is unlikely to alone provide sufficient evidence to
of national control programmes. Continued commitment from industry
d validate any promising new candidates.
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country reference centres or regional centres of excellence,
along with mechanisms to provide sustainable resources to
support scientists in malaria-endemic countries, are needed
to avail the necessary evidence-base for sustainable vector
control.
Assessing the impact of insecticide resistance on the
effectiveness of interventions is an essential but difficult
task. A number of studies on ITNs claiming to have
evaluated this have yielded differing results. Evaluations
of the impact of IRS in areas with LLINs and
pyrethroid-resistant Anopheles have also provided
different outcomes [16]. The Roll Back Malaria Partner-
ship (RBM) Vector Control Working Group commis-
sioned a systematic review of evidence on the impact of
pyrethroid resistance on ITN efficacy and malaria trans-
mission [21]. It found that poor standardization of
methodologies, inadequate controls and poor or no
characterization of underlying resistance mechanisms in
most studies precluded a definitive conclusion on the
impact of resistance on entomological outcomes or dis-
ease transmission. To address these limitations, a major
multi-country study was undertaken primarily to ascer-
tain the impact of insecticide resistance on the effective-
ness of LLINs and IRS. One of the main challenges has
been the inability to randomly allocate insecticide re-
sistance clusters within trials, necessitating prospective
observational studies of large scale to ensure sufficient
statistical power [6,22]. The project coordinated by
WHO is being implemented in Benin, Cameroon, India,
Kenya, and Sudan and will be completed in 2016. In-
terim results suggest that there are variations in the im-
pact of insecticide resistance on the effectiveness of
LLINs versus IRS, and between different settings [22].
There remains a paucity of evidence on the utility of
conventional resistance management strategies (e.g.,
insecticide rotations, mosaics, mixtures, and combina-
tions) in restoring the susceptibility of malaria vectors.
There is also a need for well-designed assessments of
the operational impact of combinations of insecticidal
and non-insecticidal interventions, including larval
source management approaches. Outcomes are likely
to be dependent on the levels of malaria parasite trans-
mission, the behaviour and the resistance profile (in-
cluding frequency, intensity and type of mechanisms)
of local mosquitoes, and coverage of interventions.
Evaluations of candidate approaches should focus on
validated cost-effective interventions that can be imple-
mented at scale within the logistical and financial con-
straints of the national malaria control programmes.
Consideration should also be given to economic con-
straints or opportunities, such as decreasing commod-
ity and implementation costs that may result during
scale-up.Pillar V Ensure that enabling mechanisms (advocacy,
human and financial resources) are in place
High-level representatives from all key constituencies of
the global malaria community participated in the launch of
GPIRM in May 2012. The executive summary of GPIRM
was made available in English, French and Spanish in hard
copy and on the WHO website, and was circulated widely
through various avenues including RBM working groups
and sub-regional networks. The World Malaria Report
2014 [1] includes a section that summarizes the status
of insecticide resistance on the basis of information
from the newly established WHO global insecticide re-
sistance database.
These advocacy initiatives have catalysed open engage-
ment and communication on the extent and implica-
tions of insecticide resistance, yet the human and
financial resources committed to tackling this problem
are inadequate. In parallel to the development and dis-
semination of GPIRM, efforts to mobilize financial re-
sources to support its implementation were undertaken
by various groups, including WHO, RBM and CDC.
These included approaching traditional donors as well
as exploring innovative ways to engage non-traditional
donors for independent management of funds from
sources including the private sector. While this resulted
in investments for some activities such as resistance
monitoring and global databases, these fell far short of
the necessary finances required to support GPIRM im-
plementation. This is in stark contrast to the efforts and
resources that have been committed to curtailing the
spread of malaria parasite resistance [23].
One of the major limitations to widespread support
for GPIRM has been the lack of availability of non-
pyrethroid LLINs and options for IRS restricted to only
two MOA. Furthermore, access to IRS formulations of
acetylcholinesterase inhibitors (organophosphates and
carbamates) has largely been limited by their high cost
relative to pyrethroids; their use has often necessitated a
reduction in IRS coverage due to a lack of financial re-
sources to compensate for the cost increase. This barrier
to access has been exacerbated by the lack of evidence
on comparative cost-effectiveness of IRS formulations
with different residual efficacy, and limited capacity at
the country level to use such evidence for local decision-
making.
Attempts by WHO to engage industry partners on po-
tential price concessions for existing or new IRS prod-
ucts have had limited success. The US President’s
Malaria Initiative also attempted to discuss pricing with
industry, and has advocated for insecticide manufac-
turers to look into price elasticity models, i.e., if price
goes down, quantity purchased goes up to reach an equi-
librium point. This has not been successful in part be-
cause a high commodity price and a single supplier for
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has led to a small, chaotic marketplace and low uptake,
resulting in a lack of reliable, long-term demand fore-
casting. Using their experience with LLIN procurement,
the Global Fund to Fight AIDS, Tuberculosis and Malaria
is considering engaging with industry on a new procure-
ment strategy for IRS in 2015. It should be noted that the
basic cost of manufacture of the non-pyrethroid alterna-
tives, whatever the volume, will nevertheless be signifi-
cantly higher than that of pyrethroids. The factors
limiting programme access to non-pyrethroids, such as
reductions in costs for the overall management and im-
plementation of quality IRS, must be addressed in order
to achieve and sustain universal access to effective mal-
aria vector control.
Conclusions and the way forward
For most malaria-endemic countries, and particularly
those in Africa south of the Sahara, pyrethroid resistance
in malaria vectors is worsening. There are also increas-
ing reports of resistance to organophosphates, carba-
mates and DDT. Pre-emptive action against insecticide
resistance as emphasized in GPIRM is still the goal, but
immediate measures are needed to address pyrethroid
resistance. However, the options for LLINs and IRS re-
main limited, which further challenges the goal of pre-
serving the effectiveness of malaria vector control and
providing universal access of at-risk populations to mal-
aria prevention. Some progress has been made in imple-
menting GPIRM. There has been enhancement in
capacity and resources for insecticide resistance moni-
toring [1], development of new IRS formulations with
extended efficacy and the establishment of global and re-
gional insecticide resistance databases. However, whilst
some countries have switched from using pyrethroids in
IRS, most have yet to establish and implement national
insecticide resistance monitoring and management plans
that incorporate ongoing rotation of insecticides with
different MOA. Key limitations to the uptake of GPIRM
have been the lack of vector control tools with new
MOA, and major financial, human and infrastructural
resource deficiencies.
Until non-pyrethroid, multi-insecticide LLINs are
available, insecticide resistance will, to a great extent,
rely on the targeted use of rotational IRS with different
MOA. However, a decline in the global at-risk popula-
tion protected with IRS restricts options for resistance
management. With the high cost of current pyrethroid
alternatives being one of the main barriers to imple-
menting GPIRM technical recommendations, it is vital
that options for improving affordability are urgently pur-
sued. Better global forecasting of insecticide require-
ments, pooled procurement and long-term agreements
and tax-free incentives have been successfully applied tothe LLIN market. These approaches may be feasible to
enhance the confidence of IRS chemical manufacturers,
help stabilize the market and eventually lead to price re-
ductions. Together, these actions may support the main-
tenance and/or scale-up of IRS for insecticide resistance
management purposes, which must be conducted in par-
allel with enhanced entomological surveillance coupled
with efficient data management to inform programmatic
decisions. Moreover, tracking the status of insecticide re-
sistance and progress in GPIRM implementation will re-
quire the identification and regular measurement of
both national and global key indicators.
The majority of countries currently implementing IRS
depend heavily on external donor support, especially in
Africa. Countries and partners are therefore urged to de-
velop and implement national insecticide resistance
monitoring and management plans that include contin-
gencies for ongoing use of more expensive alternative
IRS insecticides as part of national strategic plans. Re-
source mobilization should also be pursued from non-
traditional donors to ensure the full cost of deploying
non-pyrethroid IRS is covered, and can be justified on the
basis that programmatic cost increases will be inevitable
in the face of resistance. There is a need for enhanced in-
vestments by endemic countries coupled with strategic
plans for transitioning to full financing and management
of vector control activities wherever feasible.
In parallel to these efforts, additional investments
should be made to build country capacity to monitor in-
secticide resistance, including quantifying resistance in-
tensity and assessing its operational impact. Often the
need for and actual role of public health entomologists
supporting malaria control programmes is not clear to
those at higher management levels. The skills set re-
quired for senior personnel coordinating entomological
surveillance as well as vector control implementation,
monitoring and evaluation (which may require different
staff and expertise) should be clearly defined on the basis
of programme needs.
Country reference centres run in collaboration with
the national malaria control programme should be
established, potentially by upgrading existing institutions
with the necessary facilities. The complexity of charac-
terizing the underlying resistance mechanisms means
that establishing capacity for these assessments, which
will require additional investments, will not be practical
in all malaria-endemic countries. Country, regional or
global centres that can rapidly assess mechanisms and
feedback results in a timely manner should be estab-
lished to work alongside national programmes to ensure
optimal uptake and use of information. This will help in
building capacity of scientists from developing countries,
particularly those working in national malaria control
programmes. A mechanism is also needed to ensure that
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own countries that have been acquired elsewhere. Spe-
cialized re-entry grants, such as those issued by the
WHO Special Programme for Research and Training in
Tropical Diseases, should be implemented to address
this problem.
WHO must support these initiatives by building
awareness and consensus around the extent of the prob-
lem of insecticide resistance - similar to those efforts
with artemisinin resistance - and should explore ways to
ensure that alternative products for managing insecticide
resistance are affordable. With the current knowledge and
experience, it would be irresponsible for the global com-
munity to wait until malaria programmes report increases
in malaria cases due to insecticide resistance before there
is a significant response. Moreover, to continue to witness
declines in IRS coverage due to a lack of incorporating
non-pyrethroids is unacceptable. Global inaction deprives
affected communities of their basic right of universal ac-
cess to effective protection against malaria. A global re-
sponse plan for insecticide resistance in malaria vectors is
under development by WHO. Using GPIRM as the tech-
nical basis, this will clearly outline the actions required by
national malaria control programmes and their partners
and the indicators to track progress in addressing the
challenge of insecticide resistance.
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